let you Obag Nu-Derm Clear Generic Name: hydroquinone Dosage Form: cream, lotion Overview Side Effects Dosage Professional Pregnancy More User Reviews Support Group Q & A Pricing & Coupons Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here. Obagi Nu-Derm Clear (Hydroquinone USP, 4%) Skin Bleaching Cream Obagi Nu-Derm Blender (Hydroquinone USP, 4%) Skin Bleaching Cream Obagi Nu-Derm Sunfader (Hydroquinone USP, 4%; Octinoxate USP, 7.5%; Oxybenzone USP, 5.5%) Skin Bleaching Cream with Sunscreens Rx Only For external use only Slideshow Drug Treatments for Rheumatoid Arthritis - What Are Your Options? Obag Nu-Derm Clear Description Hydroquinone is 1, 4-benzenediol. The drug is freely soluble in water and in alcohol. Chemically, hydroquinone is designed as p-dihydroxybenzene; the empirical formula is C 6 H 6 O 2 ; molecular weight is 110.11 g/mol. The chemical structure is in the diagram below. Each gram of Obagi Nu-Derm Clear contains: Active ingredient: Hydroquinone USP, 4% (40 mg/g) Inactive ingredients: water, cetyl alcohol, glycerin, sodium lauryl sulfate, stearyl alcohol, lactic acid, tocopheryl acetate, ascorbic acid, sodium metabisulfite, disodium EDTA, methylparaben, BHT, propylparaben, saponins, butylparaben Each gram of Obagi Nu-Derm Blender contains: Active ingredient: Hydroquinone USP, 4% (40 mg/g) Inactive ingredients: water, glycerin, cetyl alcohol, PPG-2 myristyl ether propionate, sodium lauryl sulfate, TEA-salicylate, lactic acid, phenyl trimethicone, tocopheryl acetate, sodium metabisulfite, ascorbic acid, methylparaben, disodium EDTA, propylparaben, saponins, BHT Each gram of Obagi Nu-Derm Sunfader contains: Active ingredients: Hydroquinone USP, 4% (40 mg/g); Octinoxate USP, 7.5%; Oxybenzone USP, 5.5% Inactive ingredients: water, cetyl alcohol, glycerin, sodium lauryl sulfate, stearyl alcohol, tocopheryl acetate, ascorbic acid, sodium metabisulfite, disodium EDTA, methylparaben, BHT, saponins, propylparaben, butylparaben Obag Nu-Derm Clear - Clinical Pharmacology Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3, 4-dihydroxyphenylalanine (DOPA) and suppression of other melanocyte metabolic processes. Exposure to sunlight or ultraviolet light will cause repigmentation of the bleached areas, which may be prevented by the use of sunblocking agents or sunscreen agents contained in Obagi Nu-Derm Sunfader and Obagi Nu-Derm Sun Shield Matte Broad Spectrum SPF 50. Indications and Usage for Obag Nu-Derm Clear For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation. Contraindications People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established. Warnings Hydroquinone is a skin-bleaching agent, which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product. Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin and check within 24 hours. Minor redness is not a contraindication, but where there is itching or vesicle formation or excessive inflammatory response, product should be discontinued and physician consulted. Close patient supervision is recommended. Warnings: Avoid contact with eyes, nose, mouth, and lips.In case of accidental contact, patient should rinse thoroughly with water and contact a physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity. Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people . Precautions (Also see WARNINGS ) Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment. Pregnancy Category C Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated. Nursing Mothers It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother. Pediatric Usage Safety and effectiveness in children below the age of 12 years have not been established. Adverse Reactions No systemic adverse reactions have been reported. Occasional hypersensitivity (localized contact dermatitis) may occur, in which case the product should be discontinued and the physician notified immediately. Obag Nu-Derm Clear Dosage and Administration A thin application should be applied once or twice daily or as directed by a physician. If no improvement is seen after three (3) months of treatment, use of this product should be discontinued. Sun exposure should be limited by using a sunscreen agent, a sunblocking agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring. How is Obag Nu-Derm Clear Supplied Obagi Nu-Derm Clear is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-101-36 Obagi Nu-Derm Blender is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-100-36 Net wt. 1 oz. (28 g) bottle NDC 62032-100-10 Obagi Nu-Derm Sunfader is available as follows: Net wt. 2 oz. (57 g) bottle NDC 62032-116-36 Store at controlled room temperature: 15 C-25 C (59 F-77 F). Keep out of direct sunlight. Blender, Obagi Nu-Derm, and Sunfader are registered trademarks of OMP, Inc. Distributed by OMP, Inc. Long Beach, CA 90806 1-800-636-7546 2012 Obagi Medical Products, Inc. All rights reserved. www.obagi.com Made in USA 30700311Z Rev. 09/12 PRINCIPAL DISPLAY PANEL - 57 g Bottle Label OBAGI NU-DERM NDC 62032-101-36 AM CLEAR PM 3 SKIN BLEACHING & CORRECTOR CREAM HYDROQUINONE USP, 4% Rx ONLY Net wt. 2 oz. (57g) PRINCIPAL DISPLAY PANEL - 57 g Bottle Label OBAGI NU-DERM NDC 62032-100-36 BLENDER PM 5 SKIN LIGHTENER & BLENDING CREAM HYDROQUINONE USP, 4% Rx ONLY Net wt. 2 oz. (57g) PRINCIPAL DISPLAY PANEL - 57 g Bottle Label OBAGI NU-DERM NDC 62032-116-36 AM SUNFADER 6 SKIN LIGHTENER WITH SUNSCREEN (SPF 15) PABA FREE HYDROQUINONE USP, 4% Rx ONLY NET WT. 2 OZ. (57g) NU-DERM CLEAR SKIN BLEACHING AND CORRECTOR hydroquinone cream Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:62032-101 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g Inactive Ingredients Ingredient Name Strength WATER CETYL ALCOHOL GLYCERIN SODIUM LAURYL SULFATE STEARYL ALCOHOL LACTIC ACID .ALPHA.-TOCOPHEROL ACETATE ASCORBIC ACID SODIUM METABISULFITE EDETATE DISODIUM METHYLPARABEN BUTYLATED HYDROXYTOLUENE PROPYLPARABEN BUTYLPARABEN Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:62032-101-36 57 g in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/1988 NU-DERM BLENDER SKIN LIGHTENER AND BLENDING hydroquinone cream Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:62032-100 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g Inactive Ingredients Ingredient Name Strength WATER GLYCERIN CETYL ALCOHOL PPG-2 MYRISTYL ETHER PROPIONATE SODIUM LAURYL SULFATE TROLAMINE SALICYLATE LACTIC ACID PHENYL TRIMETHICONE .ALPHA.-TOCOPHEROL ACETATE SODIUM METABISULFITE ASCORBIC ACID METHYLPARABEN EDETATE DISODIUM PROPYLPARABEN BUTYLATED HYDROXYTOLUENE Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:62032-100-10 28.5 g in 1 BOTTLE, PLASTIC 2 NDC:62032-100-36 57 g in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/1988 NU-DERM SUNFADER SKIN LIGHTENER WITH SUNSCREEN (SPF 15) PABA FREE hydroquinone, octinoxate, and oxybenzone lotion Product Information Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:62032-116 Route of Administration TOPICAL DEA Schedule Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g OCTINOXATE (OCTINOXATE) OCTINOXATE 75 mg in 1 g OXYBENZONE (OXYBENZONE) OXYBENZONE 55 mg in 1 g Inactive Ingredients Ingredient Name Strength WATER CETYL ALCOHOL GLYCERIN SODIUM LAURYL SULFATE STEARYL ALCOHOL .ALPHA.-TOCOPHEROL ACETATE ASCORBIC ACID SODIUM METABISULFITE EDETATE DISODIUM METHYLPARABEN BUTYLATED HYDROXYTOLUENE PROPYLPARABEN BUTYLPARABEN Product Characteristics Color WHITE Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description 1 NDC:62032-116-36 57 g in 1 BOTTLE, PLASTIC Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 01/01/1984 Labeler - OMP, INC. (790553353) Establishment Name Address ID/FEI Operations PureTek Corporation 785961046 MANUFACTURE(62032-101, 62032-100, 62032-116), LABEL(62032-101, 62032-100, 62032-116), PACK(62032-101, 62032-100, 62032-116) Establishment Name Address ID/FEI Operations Ei LLC 105803274 MANUFACTURE(62032-101, 62032-100, 62032-116), LABEL(62032-101, 62032-100, 62032-116), PACK(62032-101, 62032-100, 62032-116), ANALYSIS(62032-101, 62032-100, 62032-116) Revised: 06/2014 OMP, INC. Next Pregnancy Warnings Print this page Add to My Med List More about hydroquinone topical Side Effects During Pregnancy Dosage Information Support Group Pricing & Coupons 5 Reviews Add your own review/rating Drug class: topical depigmenting agents Consumer resources Hydroquinone topical Hydroquinone Hydroquinone with Sunscreen Cream and Gel Professional resources Hydroquinone (AHFS Monograph) Hydroquinone Cream (FDA) Hydroquinone Cream with Sunscreens (FDA) Hydroquinone Time Release Cream (FDA) Hydroquinone (Wolters Kluwer) Other brands: Melamin , Lustra , Melquin HP , Melpaque HP , ... +19 more Related treatment guides Dermatological Disorders} FEATURED: CAR-T Cell Therapy Overview Mechanism of Action KTE-C19 Studies KTE-C19 Cancer Targets Adverse Events Manufacturing Drug Status Rx OTC Availability Rx and/or OTC C Pregnancy Category Risk cannot be ruled out N/A CSA Schedule Not a controlled drug Manufacturers Perrigo Company Acella Pharmaceuticals, LLC Drug Class Topical depigmenting agents Related Drugs topical depigmenting agents hydroquinone topical , Melamin , Tri-Luma , Lustra Dermatological Disorders triamcinolone , clobetasol topical , betamethasone topical , Temovate , Diprolene , Analpram-HC , Celestone , urea topical , Valisone , Clobex , Proctofoam HC , sodium hyaluronate topical , hydroquinone topical , Olux , Betamethacot , Diprosone , salicylic acid topical , Diprolene AF , Melamin , Celestone Soluspan , Analpram E , Clobevate , More... Hydroquinone topical Rating 5 User Reviews 2.8 /10 5 User Reviews 2.8 Rate it!} } premiere
looking ahead to Obag Nu-Derm Clear nowadays
EmoticonEmoticon